Complement Activation and Prognosis in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial

OBJECTIVE: The activation of the complement system may be involved in the pathology of myocardial infarction (MI) and type 2 diabetes. To explore their potential as prognostic markers, we characterized two factors in the complement cascade, the end product sC5b-9 and the mannose-binding lectin–assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellbin, Linda G., Bjerre, Mette, Thiel, Steffen, Hansen, Troels K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308270/
https://www.ncbi.nlm.nih.gov/pubmed/22357179
http://dx.doi.org/10.2337/dc11-1642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308270/
https://www.ncbi.nlm.nih.gov/pubmed/22357179
http://dx.doi.org/10.2337/dc11-1642

Ejemplares similares